Med-spa AI visibility playbook: beat the Allergan citation monopoly in 2026

The first thing every independent med-spa loses to AI engines is the brand fight. Not because the practice is invisible to Google — most book three to five months out — but because ChatGPT, Claude, and Perplexity are answering “best Botox in [city]” with the manufacturer.

Why ChatGPT recommends Botox the brand and not your med-spa

This is the citation hierarchy every American Med Spa Association (AmSpa) member is waking up to in 2026. The med-spa industry crossed $20 billion in revenue in 2025, with roughly 8,000 to 10,000 practices operating in the US — 81% of them as single locations per AmSpa’s industry baseline. The market is on a 14.6% CAGR to $45.5 billion by 2030 (Metricus MedSpa AI Visibility 2026). And the buyer is now arriving through a different funnel: 40% of patient searches are projected to use AI by 2026 (Cornflower 2026), and 45% of consumers already use AI assistants to find local services (Metricus Home Services 2026). “Botox near me” alone clears one million monthly searches.

The buyer is asking the engine. The engine is answering with Allergan.

This playbook is the hub for ConnectEra’s two med-spa clusters — the Allergan citation monopoly breakdown and the Texas SB 378 med-spa website audit — and it sits inside the broader vertical citation playbooks hub where seven other verticals get the same treatment. If your practice is on Squarespace, read the Squarespace canonical trap first; the platform constraint is upstream of every fix below.

Who actually searches “best Botox in [city]” on ChatGPT in 2026

The buyer-side AI adoption math is no longer hypothetical. Cornflower’s 2026 industry survey put 40% of patient searches on AI by year-end. Metricus’s home-services adjacent data has 45% of consumers using AI assistants for local-service discovery — a number that maps cleanly to aesthetic-procedure searches because both sit at the intersection of trust, local availability, and price-shopping. AmSpa’s working baseline of $1.2M to $2.5M annual revenue per single-location med-spa, with average per-visit spend in the $500-plus range, means each AI-sourced patient is a multi-year revenue relationship — neuromodulator patients return every three to four months on average.

The patient profile that matters is the new aesthetic patient. Not the loyal Allē rewards member who already has an injector and just rebooks. The first-time Botox, lip filler, or CoolSculpting buyer who Googles or, increasingly, prompts ChatGPT before walking into a consultation. Per the Haute MD and 5WPR Medical Aesthetics AI Visibility Index released April 25 2026 — the first published audit of the category — these are the brands that win the answer:

Rank	Entity	Type	AI mention rate (2026)
1	Allergan/AbbVie (Botox/Juvéderm)	Manufacturer	90%+
2	RealSelf	Marketplace	~75%
3	Ideal Image	National chain	~65%
4	LaserAway	National chain	~55%
5	Galderma	Manufacturer	~50%
6	Sono Bello	National chain	~40%
7	SkinSpirit	Regional chain	~25%
8	Aedit	Marketplace	~20%
—	Average independent med-spa	1–3 locations	below 1%

Source: Metricus MedSpa AI Visibility 2026.

The Haute MD and 5WPR index ranked the top 15 brands as 62% of total citation share across ChatGPT, Claude, Perplexity, and Google AI Overviews — measured against 60-plus queries spanning a $22 billion global market scope. Top five by category mention: Botox, Juvéderm, CoolSculpting, SkinCeuticals, Morpheus8.

Reddit is the cross-LLM citation source #1 per the 5WPR AI Platform Citation Source Index 2026, and the relevant subreddits — r/30PlusSkinCare, r/Skincare_Addiction, r/PlasticSurgery — overlap heavily with patient-research behaviour. If your practice is invisible inside r/30PlusSkinCare, you are invisible inside the engine that retrieves from it.

The 8-tier med-spa citation hierarchy in 2026

There are eight surfaces an AI engine consults before recommending a med-spa. They are not equal in weight, and most independent practices are present on fewer than three. The full hierarchy:

1. Manufacturer entity graphs. Allergan’s Allē rewards programme, the legacy Brilliant Distinctions database, the Juvéderm provider locator, Botox.com, MyAllergan. Galderma’s Aspire programme. Skinmedica’s locator. These are server-rendered, schema-rich, and updated continuously by manufacturers that spend nine figures a year on digital infrastructure.

2. The AmSpa directory. The American Med Spa Association directory is the trade-association entity layer. Membership is verifiable. Inclusion is non-negotiable for any practice that takes regulatory positioning seriously.

3. RealSelf. 10K-plus aesthetic providers across 115 countries, rebranded in 2025, with AI features on the 2026 product roadmap (BeautyMatter 2026). RealSelf takes 75% of marketplace citations not because it is editorially better but because it is older, denser, and has a content flywheel manufacturers do not control.

4. National-chain authority pages. Ideal Image (65% AI mention rate), LaserAway (55%), Sono Bello (40%). These chains aggregate hundreds of locations under one schema spine. An independent in their metro is competing with the chain’s national page authority on every “best Botox in [metro]” query.

5. State-board verifiable licensure pages. Texas Medical Board, California Board of Registered Nursing, Florida Department of Health. AI engines cross-check licensure for medical-procedure recommendations because the regulatory exposure is real. A practice that surfaces its license numbers in schema (Person + hasCredential) gets favoured over one that does not.

6. PubMed and primary medical literature. Perplexity in particular rewards primary sources. A practice that has clinicians published in the Aesthetic Surgery Journal or Plastic and Reconstructive Surgery is cited at a meaningfully higher rate than a peer with an identical revenue profile but no peer-reviewed presence.

7. Reddit and patient-experience forums. Cross-LLM citation source #1. Authentic, opinionated, hard to fake without FTC exposure (more on that below).

8. The practice’s own website. Last on the list — and only material if the schema, freshness, and entity-graph signals are right. Most independents stop here, which is why most independents lose.

The brand-lock problem is real. Haute MD and 5WPR’s April 2026 index found that branded queries — “best Botox,” “Juvéderm vs Restylane,” “CoolSculpting vs SculpSure” — return manufacturer-graph answers that do not surface practitioners at all unless the practitioner is named on a manufacturer’s locator page. Allergan’s locator surfaces practices that are Allē-active and have a minimum-volume relationship. Galderma Aspire surfaces practices in good standing with the manufacturer. Outside those locators, the manufacturer answer ends and the marketplace answer begins — and the marketplace is RealSelf.

The arbitrage is one layer down: procedure-level and metro-level. “Top med-spa for Morpheus8 in San Antonio, week of” is not in any manufacturer’s index. Haute MD and 5WPR’s brand-only ranking does not reach there. That is the empty category.

The 15 prompts patients actually ask before they walk in

Verified from Metricus 2026 and Cornflower 2026’s analysis of patient-side AI prompt patterns. These are the queries shaping the consult-form pipeline today:

1. “What should I know before getting Botox?”
2. “What are the best medspa chains in the US?”
3. “How do I choose between Botox and Dysport?”
4. “Best place to get lip filler”
5. “Where should I get Botox?”
6. “How do I find a good medspa near me?”
7. “How long does lip filler last?”
8. “Botox vs Dysport — which is better for forehead lines?”
9. “Best HydraFacial near me”
10. “Top medspa for CoolSculpting in Miami”
11. “Is Sculptra better than Radiesse?”
12. “Where can I get Morpheus8 in Manhattan?”
13. “Safest place for laser hair removal LA”
14. “Top RealSelf-rated injector Houston”
15. “Best medspa for skin tightening near me”

Read those again. Notice the pattern. The consumer prompts are evenly split between brand-decision queries (1, 3, 8, 11) and metro-procedure queries (5, 6, 10, 12, 13, 14, 15). The brand-decision queries are unwinnable for an independent — Allergan and Galderma’s content flywheel will always rank higher on “Botox vs Dysport.” The metro-procedure queries are winnable, and they are the ones that convert into a $536-per-visit consultation.

Patient prompts 12 and 14 are particularly instructive. “Where can I get Morpheus8 in Manhattan” rewards practices that have published procedure-page content with MedicalProcedure schema, named-injector Person schema, and metro-level NAP consistency. “Top RealSelf-rated injector Houston” rewards practices with a populated RealSelf profile (the $99 to $899/month tier) plus their own server-rendered review schema citing those same RealSelf review counts. Two of the fifteen high-intent prompts route through RealSelf as the authority spine. That is not a coincidence.

Citation directories and the brand-lock problem

There are five directories AI engines actually cite for the medical-aesthetic vertical. The hierarchy stays the same across ChatGPT, Claude, Perplexity, and Google AI Overviews; the weighting shifts.

The AmSpa directory is the AmSpa-affiliated practice’s first asset. It surfaces in regulatory and “is this practice legitimate” prompts more than in commercial ones, but it carries entity-verification weight that compounds across queries.

RealSelf at 75% marketplace mention rate. The pricing tiers — Pro Lite, Pro, Pro Plus — gate access to review responses, before/after galleries, and Q&A presence. The 64.3% authentic / 35.7% fake review classification rate from the peer-reviewed ScienceDirect study (analysing 9,000 RealSelf reviews) is the freshness signal Perplexity in particular respects. Practices with verified-review density rank above practices with cosmetic-volume density.

Allergan Brilliant Distinctions / Allē, Galderma Aspire, and Skinmedica’s locator are the three manufacturer programmes that the engines consult for “where can I get [branded product].” Locator inclusion is a function of manufacturer-account standing, not website quality. This is the brand-lock layer: a practice can have the best-built website in its metro and still not surface for “Juvéderm in [city]” if the Allē account is dormant.

PubMed/NIH for the medical-authority surface, particularly on Perplexity. Practices with published clinicians get citation lift on procedural-mechanism queries (“how does Morpheus8 work,” “what is the safety profile of Sculptra”) that funnel into commercial intent downstream.

The brand-lock problem is that 90%+ of citations on branded queries route through manufacturer entity graphs the practice does not control. The architectural answer is to stop competing on branded queries and start owning unbranded procedure × metro queries — the empty category Haute MD and 5WPR’s index does not reach.

Texas SB 378, NYC December 2025, Florida HB 1429: the regulatory citation hooks

State-board enforcement turned into a 2026 newsjack. Three events in the eighteen months ending May 2026 reset the regulatory ceiling on med-spa positioning:

Texas SB 378 (2026) closes the long-standing Texas med-spa loophole. Only qualifying medical license-holders can perform injections — physician, physician assistant, advanced practice registered nurse, or registered nurse under appropriate delegation, regardless of the prior tenure or “we’ve always done it this way” defence. The American Academy of Aesthetics TX has a clean explainer of the bill’s scope. Every Texas med-spa must reaudit. State-by-state ownership rules — corporate practice of medicine restrictions, RN-versus-LVN injection authority, physician medical-director requirements — are the regulatory layer AI engines now consult on safety-of-procedure prompts.

NYC Council and State joint investigation, December 11 2025: 100% of fifteen inspected med-spas had violations. The press release names the practices and the violation categories. This is the kind of regulatory event that AI engines retrieve as a freshness signal on “is med-spa X safe” queries — and the kind that compliant, transparent practices can quote in patient-education content without sounding defensive.

Florida HB 1429 added expedited injunction route and immediate registration revocation power for refusing inspection (Florida Healthcare Law Firm 2026; AmSpa 2026 deep-dive). Florida med-spas that publish their compliance posture as patient-education content get rewarded by the engine; med-spas that bury it lose to the ones that lead with it.

The FTC Endorsement Guides (December 2025 update via Arnold & Porter) added that virtual and AI endorsers are held to the same standard as human ones. Influencer disclosure is required for cash, free product, discount, or affiliate compensation. The risk is real for med-spas using GenAI-generated patient testimonials — the ScienceDirect study cited 64.3% authenticity / 35.7% fake-review rates across 9,000 RealSelf reviews. Fake-review enforcement is on the table.

The compliance-as-citation play is straightforward. Publish a <FAQPage> block that names the relevant state law, the practice’s licensure posture, and the safety implication for the patient. Update it on the dates the laws take effect. The Wednesday data-drop angle ConnectEra runs is “Texas SB 378 + 30 med-spa websites that now violate state law” — a published audit list, citable by URL. Practices that audit themselves first stay off the list.

Why MedicalBusiness + Physician + MedicalProcedure schema overflows the Wix 8K cap

The schema stack a serious med-spa needs is not optional. It is:

• MedicalBusiness (the practice as a regulated medical entity, distinct from LocalBusiness)
• Physician for each provider (one block per injector, each with medicalSpecialty, availableService, hasCredential)
• MedicalProcedure for each service (Botox, Juvéderm, CoolSculpting, Morpheus8, HydraFacial, laser hair removal, chemical peels — each with procedureType, bodyLocation, preparation, followup)
• FAQPage (procedural FAQs feeding the answer engine; see the FAQPage entity-graph that earns the citation)
• Review and AggregateRating nested inside the relevant MedicalBusiness or MedicalProcedure

That stack, populated honestly for a four-injector single-location med-spa with twelve services, runs comfortably past 12,000 characters of JSON-LD. Wix Studio caps total on-page schema markup at 8,000 characters with a 7,000-character per-entry ceiling, and natively supports only Article/Product/Event presets — MedicalBusiness, Physician, Service, and FAQPage all require manual JSON-LD via Velo or the SEO panel (Wix Help Center; Search Engine Journal Wix Structured Data Guide). The cap forces a choice between the entity layers, and every choice loses citation share. The deeper analysis lives in the Wix AI ceiling and in the platform-vs-AI citation guide for 2026.

Squarespace 7.1 caps differently. Schema is auto-injected for LocalBusiness and Person but not user-editable. There is no path to add MedicalBusiness or Physician cleanly. Median mobile LCP sits at 3.6 to 3.8 seconds. The canonical tag is locked. Every Squarespace 7.1 site ships with a permanent /home → / mismatch warning in Search Console — see the Squarespace canonical trap for the full breakdown of why this is upstream of every other fix.

WordPress with a developer behind it can ship the full schema stack server-side without a character cap. Webflow at the luxury tier ($10K-plus med-spas per The MedSpa Society 2026) handles it cleanly. The decision tree:

• Boutique single-location, $1.2M–$2M revenue, content-light: a Squarespace 7.1 site is not the right platform if AI citation matters. Static rebuild is the only fix.
• Multi-provider, content-heavy, $2M–$5M revenue: WordPress with a custom theme and developer-managed schema, or a static rebuild on Astro / Next.js.
• $10K-plus luxury practice, regional or multi-location: Webflow with custom JSON-LD or a fully static stack. Anything else is leaving citation share on the table.

The deeper technical architecture — the answer-capsule format, the FAQPage schema mechanics, the entity graph that earns the citation — lives in the get-cited-by-AI technical pillar. The sequence is platform first (the ceiling), then schema and entity (the floor), then content cadence (the velocity).

The Wednesday data-drop angle: provider-level Botox citation share × 10 metros

The empty category Haute MD and 5WPR’s April 2026 index does not reach is provider-level. They stopped at brand-level rankings — Botox, Juvéderm, CoolSculpting in the top three, Morpheus8 and SkinCeuticals rounding out the top five. ConnectEra’s Wave-1 data drop runs the layer they skipped.

The methodology is reproducible. Pick ten metros that index high on aesthetic-procedure search volume — Manhattan, Houston, San Antonio, Miami, LA, Atlanta, Dallas, Chicago, Phoenix, Scottsdale. Run the same fifteen patient prompts above through ChatGPT, Claude, Perplexity, and Google AI Overviews. Tally which med-spa names — not just brand names — surface in the answer set. Publish the metro × procedure citation matrix as a Wednesday data drop, dated and reproducible.

The result is the first published provider-level citation share scan for the medical-aesthetic vertical. Practices on the list win citation lift on metro-procedure prompts. Practices not on the list see what their competitors look like at the citation layer. The data drop itself is the kind of original primary source AI engines cite back into the cycle — which is how cross-vertical content compounds.

This is not a hypothetical. The Haute MD and 5WPR index proved the methodology works at brand level. The provider-level scan is one rung deeper, and it is the rung that matters for the 8,000 to 10,000 independent med-spas in the US that will never beat Allergan on a branded query.

What lives in this hub: the 2 med-spa clusters

The two clusters underneath this playbook attack the citation problem from opposite directions.

The Allergan citation monopoly — the brand-dominance breakdown. How Allergan and AbbVie’s manufacturer entity graph holds 90%+ of branded med-spa AI citation share, what the Allē rewards programme actually does to citation flow, why Galderma’s Aspire programme is the second-tier shadow of the same pattern, and how independent med-spas surface against a manufacturer-funded flywheel. Quotes the Haute MD and 5WPR index, the Metricus 2026 audit, and ties the brand-lock pattern to the analogous concentration maps in the named-surgeon and lawyer-directory verticals.

The Texas SB 378 med-spa website audit — the regulatory-as-citation play. Texas SB 378 takes effect in 2026 and closes the med-spa injection loophole. Florida HB 1429 added injunction power. The NYC December 2025 enforcement bust ran 100% violation. This cluster runs an audit methodology against thirty med-spa websites that newly violate state law as of the SB 378 effective date — the audit-as-publication model that Wave-1 verticals use to compound citation share through compliance positioning.

The pattern across both clusters is the same. Stop fighting on the citation layers manufacturers and marketplaces own. Build the layer underneath — provider-level, procedure-level, metro-level, regulatory-positioned — that nobody else has published. The engine retrieves what is published. The arbitrage is the gap between what AmSpa-affiliated practices know about themselves and what is actually online for the engine to find.

The implementation order, in seven steps

For an AmSpa-affiliated single-location med-spa or small chain that takes citation seriously, the order matters. Reverse it and the spend compounds in the wrong direction.

1. Audit the platform. If the site is on Squarespace 7.1, plan migration before plan content. The schema and canonical caps are the ceiling on every other fix. Wix Studio is a similar ceiling at the 8,000-character schema cap. The platform decision is the first decision.

2. Audit the manufacturer accounts. Allergan Allē, Galderma Aspire, Skinmedica locator, RealSelf. Account standing drives locator inclusion drives citation flow on branded queries. This is operations work, not GEO work, but it caps the rest.

3. Build the named-injector entity graph. Person + Physician + hasCredential + sameAs (LinkedIn, AmSpa profile, RealSelf profile, state-board licence verification URL) for every injector. This is the layer Allergan does not own and never will.

4. Build the procedure-level page architecture. One MedicalProcedure schema block per service, server-rendered, with bodyLocation, procedureType, preparation, and followup populated. FAQPage on each procedure page. AggregateRating that cites the same review counts that appear on the practice’s RealSelf profile.

5. Publish state-board content. Texas SB 378, Florida HB 1429, and the relevant state law for the practice’s metro. Patient-education framing, not compliance-blog framing. Updated on the dates the laws take effect. The freshness signal compounds.

6. Wednesday data drops. Original primary content the engines retrieve into. The provider-level citation scan, the procedural-outcome aggregations, the metro-level pricing transparency reports. Once a week. Dated. Citable.

7. Measure citation share, not Google traffic. GA4 will not show the lift. The retrieval cycle is asynchronous and the dashboard is blind to most of it. Run the same fifteen patient prompts monthly. Tally the citation count. Compare to the baseline. The number that matters is mention rate per prompt, not sessions per month.

The compounding case is straightforward. A first-time Botox patient at a $536 average per-visit spend with a $2,500 annualised relationship across multiple procedures is a four-figure relationship from one AI-cited query. Med-spas at the AmSpa-affiliated tier — single location or small chain — are the tier where the citation arbitrage pays back fastest because the relationship LTV is high enough that one win per month covers the entire content programme. Manufacturer brand citations are not winnable. Provider-level metro-procedure citations are. The ones not winning them are the ones still optimising for Google.

The reason the order above runs platform first, content last is that the citation pipeline is sequential. AI engines crawl the initial HTML response, parse the JSON-LD they find there, weight it against the entity graph for the practice’s named injectors and named procedures, cross-check against manufacturer locators and state-board licensure data, and only then surface the practice in an answer. A platform that injects schema client-side or caps it at 8,000 characters breaks the pipeline at step one. A content programme on top of a broken pipeline compounds nothing. The Wave-1 med-spas ConnectEra works with rebuild the platform first, populate the entity graph second, ship the procedure × metro pages third, and let the Wednesday data drops do the velocity work for the next twelve months.

The med-spa AI visibility playbook is not about beating Allergan. It is about competing where Allergan is not — the procedure × metro × named-provider layer that Haute MD’s index, Metricus’s audit, and the manufacturer locators all leave open. That is the gap, in 2026, that an independent med-spa can actually own.